Page last updated: 2024-11-12

phosphoramidite

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

phosphoramidite: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

phosphoramidite : A compound with the general formula (RO)2PNR2. Phosphoramidites can be regarded as phosphites that have an NR2 instead of an OH group, or as amides of phosphorous acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID10080320
MeSH IDM0397706

Synonyms (2)

Synonym
phosphoramidite
LLKYUHGUYSLMPA-UHFFFAOYSA-N

Research Excerpts

Actions

Phosphoramidites III and IV allow efficient incorporation of 5-hmC into DNA. "One-step" deprotection procedure to cleanly remove all the protecting groups.

ExcerptReferenceRelevance
"Phosphoramidites III and IV allow efficient incorporation of 5-hmC into DNA and a "one-step" deprotection procedure to cleanly remove all the protecting groups."( Syntheses of two 5-hydroxymethyl-2'-deoxycytidine phosphoramidites with TBDMS as the 5-hydroxymethyl protecting group and their incorporation into DNA.
Dai, Q; He, C; Pan, T; Song, CX, 2011
)
1.34
"Phosphoramidites III and IV allow efficient incorporation of 5-hmC into DNA and a "one-step" deprotection procedure to cleanly remove all the protecting groups."( Preparation of DNA containing 5-hydroxymethyl-2'-deoxycytidine modification through phosphoramidites with TBDMS as 5-hydroxymethyl protecting group.
Dai, Q; He, C, 2011
)
1.32

Compound-Compound Interactions

ExcerptReferenceRelevance
"Short relaxation times and small diffusion coefficients often impede reliable diffusion experiments due to insufficient signal to noise ratios, especially in low temperature studies, where in the case of small diffusion coefficients in combination with very short T(2) times and substantial convection, double-stimulated-echo experiments are required as last resort of convection-compensating DOSY pulse sequences."( Improved applicability of DOSY experiments by high resolution probes combined with gradient amplifiers of diffusion units.
Gschwind, RM; Kerssebaum, R; Zhang, H, 2009
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (662)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's336 (50.76)29.6817
2010's266 (40.18)24.3611
2020's60 (9.06)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 54.13

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index54.13 (24.57)
Research Supply Index6.56 (2.92)
Research Growth Index6.91 (4.65)
Search Engine Demand Index87.55 (26.88)
Search Engine Supply Index2.03 (0.95)

This Compound (54.13)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews20 (2.84%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other684 (97.16%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]